Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12611000297921
Ethics application status
Approved
Date submitted
15/03/2011
Date registered
21/03/2011
Date last updated
25/10/2011
Type of registration
Prospectively registered
Titles & IDs
Public title
A Randomized controlled trial comparing Topical use of Mupirocin versus Medihoney for the prevention of infection at Tenckhoff Exit Site in Peritoneal Dialysis Patients
Query!
Scientific title
A Randomized controlled trial comparing Topical use of Mupirocin versus Medihoney for the prevention of infection at Tenckhoff Exit Site in Peritoneal Dialysis Patients
Query!
Secondary ID [1]
259802
0
NIl
Query!
Universal Trial Number (UTN)
N/A
Query!
Trial acronym
TUMMIE Trial
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Peritineal Dialysis patients
261370
0
Query!
Condition category
Condition code
Renal and Urogenital
259489
259489
0
0
Query!
Kidney disease
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Once daly application of Topical Medihoney (gauze pad) approximately10 mg ( size of a pea) at Peritoneal dialysis catheter exit site once daily (the medihoney dressing will be changed daily ) compared topical application of small amount Mupirocin using cotton bud to Peritoneal dialysis catheter exit site once daily ( 12 months )
Query!
Intervention code [1]
264218
0
Treatment: Drugs
Query!
Comparator / control treatment
Medihoney (Intervention ) vs Mupirocin ( control)
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
262335
0
time to first episode of exit site infection,peritonitis or tunnel infection -whichever comes first ( clinical assessment and microbiolgy to confirm the infection)
Query!
Assessment method [1]
262335
0
Query!
Timepoint [1]
262335
0
12 months
Query!
Secondary outcome [1]
273554
0
Secondary Endpoints : whether intervention results in:
a longer time to first exit site infection ( clinical assessment / microbiology)
Query!
Assessment method [1]
273554
0
Query!
Timepoint [1]
273554
0
12 months
Query!
Secondary outcome [2]
273555
0
whether intervention results in a longer time first episode of peritonitis (clinical assessment / microbiology)
Query!
Assessment method [2]
273555
0
Query!
Timepoint [2]
273555
0
12 months
Query!
Secondary outcome [3]
273560
0
a longer time to infection-associated catheter removal
lower catheter-associated infection rates;
Meausred by number of catheter removal due to infection
Query!
Assessment method [3]
273560
0
Query!
Timepoint [3]
273560
0
12 months
Query!
Secondary outcome [4]
273589
0
a lower incidence of adverse reactions ( all adverse events will be recorded and compared between the 2 groups).
Methods used will be questionarre and occurence of resistance ( Microbiology test)
Query!
Assessment method [4]
273589
0
Query!
Timepoint [4]
273589
0
12 months
Query!
Eligibility
Key inclusion criteria
1. Patients on peritoneal dialysis.( Incident and prevalent)
2. Able to give informed consent
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
80
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
1. PD patients who had exit site infection, peritonitis, or tunnel infection within the last 4 weeks
2. Known hypersensitivity to, or intolerance of, honey or mupirocin.
3. On long term antibiotics for any reason.
4. Patients with a history of psychological illness or condition which interferes with their ability to understand or comply with the requirements of the study.
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Central randomisation
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Randomisation of patients into the two groups will be based on computer generated numbers
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Safety and efficay of Medihoney vs Mupirocin
Query!
Phase
Phase 3 / Phase 4
Query!
Type of endpoint/s
Safety/efficacy
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Suspended
Query!
Date of first participant enrolment
Anticipated
1/04/2011
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
380
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
Query!
Funding & Sponsors
Funding source category [1]
264666
0
Hospital
Query!
Name [1]
264666
0
Department of Renal Medicine
Query!
Address [1]
264666
0
Royal brisbane & Women's Hospitals
Butterfield Street,
Herston, Qld, 4029
Query!
Country [1]
264666
0
Australia
Query!
Funding source category [2]
264667
0
Commercial sector/Industry
Query!
Name [2]
264667
0
Comvita NewZealand Limited
Query!
Address [2]
264667
0
Private Bag 1, Te Puke
Phone : 64 -0800 504 959 ( No post code)
Query!
Country [2]
264667
0
New Zealand
Query!
Primary sponsor type
Hospital
Query!
Name
Department of Renal Medicine
Query!
Address
Royal brisbane & Women's Hospitals
Butterfield Street,
Herston, Qld, 4029
Query!
Country
Australia
Query!
Secondary sponsor category [1]
263804
0
Commercial sector/Industry
Query!
Name [1]
263804
0
Comvita NewZealand Limited
Query!
Address [1]
263804
0
Private Bag 1, Te Puke
Phone : 64 -0800 504 959 ( No post code
Query!
Country [1]
263804
0
New Zealand
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
266662
0
Human Reseearch and ethics Committee
Query!
Ethics committee address [1]
266662
0
Royal Brisbane &Woen's hospitals
Herston, Qld, 4029
Query!
Ethics committee country [1]
266662
0
Australia
Query!
Date submitted for ethics approval [1]
266662
0
26/10/2010
Query!
Approval date [1]
266662
0
24/01/2011
Query!
Ethics approval number [1]
266662
0
HREC/10/QRBW?422
Query!
Summary
Brief summary
not recruiting
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
32326
0
Query!
Address
32326
0
Query!
Country
32326
0
Query!
Phone
32326
0
Query!
Fax
32326
0
Query!
Email
32326
0
Query!
Contact person for public queries
Name
15573
0
Dwarakanathan Ranganathan
Query!
Address
15573
0
Department of Renal Medicine,
Butterfield Street,
Royal Brisbane & women's Hospitals
Herston, Qld, 4029
Query!
Country
15573
0
Australia
Query!
Phone
15573
0
61-7-36368576
Query!
Fax
15573
0
61-7-36368572
Query!
Email
15573
0
[email protected]
Query!
Contact person for scientific queries
Name
6501
0
Dwarakanathan Ranganathan
Query!
Address
6501
0
Department of Renal Medicine,
Butterfield Street,
Royal Brisbane & women's Hospitals
Herston, Qld, 4029
Query!
Country
6501
0
Australia
Query!
Phone
6501
0
61-7-36368576
Query!
Fax
6501
0
61-7-36368572
Query!
Email
6501
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF